QA the AI

Monday

May 05

10:30 - 11:30

Strauss 1-2

Lung 1

Co-Chair: Lotfi Kochbati, Tunisia;

Chair: Ursula Nestle, Germany

Overview: Proffered Papers are presented in one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be recorded and available on-demand.

Session Type: Proffered Papers

Track: Clinical

Journey: Lung

10:50 - 11:00

Radiotherapy dose to non-emphysematous lung outperforms whole lung volume in predicting survival in non-small cell lung cancer patients

Presenter: , United Kingdom

Presentation Number: E25-1630

10:30 - 10:40

Impact of Different Mediastinal Staging Modalities on Target Volume Delineation in LA-NSCLC: Secondary Analysis of the Randomized PET-Plan Trial

Presenter: Eleni Gkika, Germany

Presentation Number: E25-2783

10:40 - 10:50

Is curatively intended reirradiation in lung cancer patients feasible? A retrospective study with clinical and dosimetric data

Presenter: Marianne Marquard Knap, Denmark

Presentation Number: E25-2563

11:00 - 11:10

Consolidation ICI alters cardiac subregion radiosensitivity in lung cancer patients treated with chemo-radiotherapy

Presenter: Yejin Kim, USA

Presentation Number: E25-3254

11:10 - 11:20

Highly Hypofractionated versus Standard Tumor Irradiation in Locally Advanced NSCLC with Durvalumab Maintenance: A Multicenter Retrospective Study

Presenter: Etienne CEDOZ, France

Presentation Number: E25-2992

11:20 - 11:30

ATM inhibition with AZD1390 and conventional radiotherapy in non-small cell lung cancer: interim report from the CONCORDE phase Ib trial (NCT04550104)

Presenter: , United Kingdom

Presentation Number: E25-3513

ESTRO 2025

Session